anti-LRP6 antibody (Novartis Institutes for Biomedical Research)

N/A

Report date: 2025/03/14 16:55:53

Base Information

Drug Nameanti-LRP6 antibody (Novartis Institutes for Biomedical Research)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionLow-density lipoprotein receptor-related protein 6 modulators
TargetsLow-density lipoprotein receptor-related protein 6
Therapy Area/IndicationsBone metastases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Institutes For Biomedical Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Institutes For Biomedical Research Inc
Inactive CompaniesN/A
Active IndicationsBone metastases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A